$KWG LIVING(03913)$That net profit alert of 150% increase YOY should lower the annualised PE to below 13. At this price of $7.35, it is deeply undervalued Target - $14

$AOYUAN HEALTHY(03662)$Another positive profit alert for the interim results due mid Aug 21. Not less than 50% increase YOY in net profit. EPS should increase from $0.41 to $0.60. Forward PE @ $5.18 would be 8.6 which is dirt cheap for a PM company that is delivering results. Overweight and Buy. Target = $9

$CHINA SCE GROUP(01966)$With the impending spin-off and listing of the highly profitable CM business, there is a great opportunity to profit from this spin-off. There is 1 reserved CM share for every 33 China SCE shares but I would not buy into China SCE now to enjoy the entitlement or to apply for IPO allocation of CM shares. My recommendation is to let the CM shares to be floated and traded for a few weeks and then buy in when there is a sharp correction. Valuation of PM or CM at IPO is way too high right now. Be patient and wait. 

$AOYUAN HEALTHY(03662)$With the newly revised annual caps, it means there is an agreement with China Aoyuan to raise the minimum revenue caps for Aoyuan Healthy. It is a promising sign that the actual revenue for FY2021-23 may see a revision upwards. Using FY2020 as a historical example- the FY2020 revised cap was published at 705000000 RMB and the actual came in at 1408089000 RMB, about double. Here are FY2021-23 revised annual caps and you can make a good estimate of what the future revenue would be :FY2020 - 705000000 RMB FY2021 - 1036620000 RMB (+47% YOY)FY2022 - 1381890000 RMB (+33.3%)FY2023 - 1842900000 RMB (+33.3%)The revenue growth for FY2021 can be estimated to be 47%. With FY2020 EPS of $0.41, the es

$AOYUAN HEALTHY(03662)$Just released a strong set of results for Y2020 late last night. Revenue and net profit increased YOY by 56% and 55% respectively. A final dividend of RMB0.14 or HK$0.17 was declared. PE @ $5.91 closing price were further lowered from 22 (2019 EPS of $0.27) to 14.5 (2020EPS of $0.408). Expect a sharp risein share price in the coming weeks. Assuming back to PE22, we should expect $9 per share. A consistent revenue/profit growth company and it is deeply undervalued. 

$AOYUAN HEALTHY(03662)$Amidst weak market sentiments today, Aoyuan Healthy went against the grain to move up by 7+% and this is before the final results are to be announced on 29 Mar. They already issued a positive net profit alert of not less than 50% increase. Expect further rise next week. Target $7. PE now is a mere 21 - way undervalued for a company with both consistent revenue and profit growth. 

$Alibaba Health Information Technology(00241)$It is great that Ali Health is selected to be in the HSI list of constituents by 15 Mar. from now till then, expect strong money flow to buy up the share price. JD.com enjoyed the sharp rise when they were selected some weeks back. Just do note that the strong buying usually ends on the day Ali Health becomes listed as a constituent. They were also included in HSCEI and HSTech. Good catch!

$LANGUANGJUSTBON(02606)$An offer price not less than HK$50.58 from CG Services to takeover all shares owned by the main shareholder of LabguangJustbon - 30% higher than the closing price of $38.95 before the suspension of trading. Not accepted yet, still under negotiation and suspension of trading is still active. It basically shows that many of these smaller profitable PM companies are heavily undervalued like Aoyuan Healthy01996. I personally think that the offer price is way too low - current PE of LanguangJustbon is about 11 - paying 30% more is not much more. Should be valued at PE of 30 or higher. That could be why CG Services is seeing higher value in them and could help to increase its share value with CG’s help.https://www1.h

$AOYUAN HEALTHY(03662)$Not much of an analyst coverage on this counter even after a positive profit alert. The timing of the alert just before CNY holidays is just not right. 

$AOYUAN HEALTHY(03662)$positive Profit alert announced yesterday - 50% increase YOY in net profit. This would bring the PE based on $5.20price to 15. Peers are valued at 40-70 PE. Good time to accumulate before result announcement end Mar. Target $8

$KWG LIVING(03913)$70% increase in 2020 earnings over 2019. It would mean a 2020 PE of 29. at IPO price of $7.89. $8.16 now would make a PE of 30. Further upside opportunity with 2021 earnings expected to grow again. Buy when there is a correction. 

$E-STAR CM(06668)$IPO price of $3.86 based on 2019 earning had a PE of 45. Grey market closing price of $4.40 had a PE of 52. 1st day closing price of $4 is still high with a PE of 47. I think the realistic PE should be around 40 unless 2020 earning is going to increase by 50% YOY. 

$AOYUAN HEALTHY(03662)$This counter is moving up now. It is so deeply valued with a current PE of 21 with peers at 40-70. Buy in and hold tight. The next set of results shoild reveal its attractive revenue growth and net margin. This is a mid cap and go compare their results with KWG Living 03913. 

$CHINA SCE GROUP(01966)$Undervalued given its growth in revenue and profit. Annual Dividend payout not bad too. Surprised that the market is not buying into this small cap property developer. Great potential for upside. 

$CHINA RES MIXC(01209)$If you guys are interested in profitable PM companies. Aoyuan HealthyLife (03662) is heavily undervalued. A growing medium sized PM company with net margin of 20% and has a low PE of 18. Final 2H20 results due Mar 21. Go compare performances with the bigger boys. $4.88 per unit is a steal. Target price $9.00.